IDEC-131: Began Phase II trial

Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif. Product: IDEC-131 Business: Autoimmune/Inflammation Therapeutic category: Antibody Target: CD40 ligand (also called gp39 or CD154) on T cells De...